Literature DB >> 3758237

Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells.

L C Strauss, S D Rowley, V F La Russa, S J Sharkis, R K Stuart, C I Civin.   

Abstract

The My-10 glycoprotein is an hematopoietic cell surface antigen expressed specifically by undifferentiated (blast) cells, constituting 1%-4% of normal adult bone marrow leukocytes. We used several immunological and in vitro culture methods to analyze the expression of this unique antigen on a variety of lymphohematopoietic progenitor cells. Colony-forming cells (CFC) for granulocyte-monocyte colonies (CFC-GM) and erythroid colonies (BFU-E) were predominantly My-10 positive. CFC with higher proliferative potential were more strongly My-10 positive than CFC with lower proliferative potential, and those for mixed-lineage and blast cell colonies were even more uniformly My-10 positive. Cells maintaining CFC-GM number in short-term marrow culture (pre-CFC) were found to be My-10 positive, as were lymphoid precursors defined by their content of intranuclear terminal deoxynucleotidyl transferase. More mature erythroid precursors (CFU-E) were heterogeneous for antigen expression and lost My-10 antigen progressively, in parallel with advancing maturational stage. The My-10 antigen permits rapid identification and purification of hematopoietic progenitor cells for further study or potential clinical application. The disappearance of the My-10 antigen, moreover, may be a probe for differentiation-linked cellular events.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758237

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

1.  Detection of small numbers of immature cells in the blood of healthy subjects.

Authors:  J Oertel; B Oertel; J Schleicher; D Huhn
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

2.  Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays.

Authors:  S Serke; S Säuberlich; Y Abe; D Huhn
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

3.  Inhibition of hematopoiesis by competitive binding of transcription factor PU.1.

Authors:  M T Voso; T C Burn; G Wulf; B Lim; G Leone; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

4.  Immunoblot analysis of CD34 expression in histologically diverse neoplasms.

Authors:  Y Natkunam; R V Rouse; S Zhu; C Fisher; M van De Rijn
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

Authors:  J Brandt; E F Srour; K van Besien; R A Briddell; R Hoffman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication.

Authors:  M C Re; G Zauli; G Furlini; S Ranieri; P Monari; E Ramazzotti; M La Placa
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma.

Authors:  A E Lindenmayer; M Miettinen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

Authors:  D Small; M Levenstein; E Kim; C Carow; S Amin; P Rockwell; L Witte; C Burrow; M Z Ratajczak; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Isolation of a candidate human hematopoietic stem-cell population.

Authors:  C M Baum; I L Weissman; A S Tsukamoto; A M Buckle; B Peault
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  CD 34 immunotyping of blasts in myelodysplasia.

Authors:  J Oertel; B Oertel; J Beyer; D Huhn
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.